Karen Parr brings almost 20 years’ experience in science policy, strategy, communications and engagement for government and industry bodies in Australia, New Zealand and the UK.
Karen is recognised for her ability to navigate complex stakeholder environments, forge trusted strategic partnerships and drive meaningful change within local, national and international environments.
She has worked extensively on public policy impacting life science companies, including opportunities and challenges traversing capital attraction, tax incentives, clinical trials, regulation and commercialisation of medical research. She established Australia’s Cell and Gene Catalyst and developed and launched research reports that resulted in increased global investment in Victoria and Australia.
Before joining BioMelbourne Network in June 2024, Karen was the Director of Policy and Communications at AusBiotech.
